drugset / Trial / NCT04861649

Metabonomics of COPD and Transplanting of Faecal Bacteria in the Treatment of Its Malnutrition

NCT04861649

NaSingle-groupOpen-labelTreatment

Summary

Oxidative stress can affect the balance of intestinal flora and intestinal structure of patients, resulting in intestinal flora disorder. Its bacterial metabolites stimulate the parasympathetic nerve, regulate insulin secretion and other metabolic pathways of patients through neuroendocrine regulation, resulting in abnormal energy metabolism of lipids and sugars in the digestive tract, and finally lead to malnutrition.We hypothesized that fecal bacteria transplantation could reconstruct the normal intestinal flora, restore the intestinal digestion and absorption function of chronic obstructive pulmonary disease(COPD)patients and improve the state of malnutrition.

Timeline

Start
2021-03-09
Primary completion
2023-06-30
Completion
2023-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ornidazole Other / unclassified 200 ml Other
Subject Ornidazole Other / unclassified 40 g Other

Indications

No indication recorded.